ALBIO Biosynex SA

EPA · FR · Healthcare · Medical Devices · biosynex.com

0.8780EUR-2.23%Mkt Cap: 17.59M $P/E: —Today

Biosynex SA designs, manufactures, and distributes rapid diagnostic tests to patients and healthcare professionals in France and internationally. The company develops and markets IVDs in the form of RDTs and TRODs, immun…

Industry Peers

Medical Devices

Screen all

ABT

Abbott Laboratories Common Stock

$169.83BUSDP/E 31.6

MDT

Medtronic plc. Ordinary Shares

$110.49BUSDP/E 21.2

SYK

Stryker Corporation Common Stock

$105.65BUSDP/E 28.5

BSX

Boston Scientific Corporation Common Stock

$61.74BUSDP/E 17.2

Edwards Lifesciences Corporation Common Stock

$49.03BUSDP/E 50.7

SHL

Siemens Healthineers AG

$46.06BUSDP/E 19.2

DXCM

DexCom, Inc. - Common Stock

$32.21BUSDP/E 33.7

GEHC

GE HealthCare Technologies Inc. - Common Stock

$29.24BUSDP/E 14.8

PHG

Koninklijke Philips N.V. NY Registry Shares

$23.38BUSDP/E 18.5

PHIA

Koninklijke Philips N.V.

$22.58BUSDP/E 18.5

STE

STERIS plc (Ireland) Ordinary Shares

Zimmer Biomet Holdings, Inc. Common Stock

$16.84BUSDP/E 21.4

PEN

Penumbra, Inc. Common Stock

$12.51BUSDP/E 77.8

TXG

10x Genomics, Inc. - Common Stock

$12.18BUSD

SNN

Smith & Nephew SNATS, Inc. Common Stock

$11.06BUSDP/E 18.0

GMED

Globus Medical, Inc. Class A Common Stock

Bio-Rad Laboratories, Inc. Class A Common Stock

$9.88BUSDP/E 45.0

GKOS

Glaukos Corporation Common Stock

$9.66BUSD

Key Statistics

Company

Market Cap17.59M USD

Enterprise Value75.81M USD

Revenue (TTM)103.47M USD

Gross Profit56.91M USD

Net Income (TTM)-63.29M USD

Revenue/Share5.17 EUR

Last Price0.8780 EUR

Fiscal Year EndDec 2025

MR QuarterDec 2025

Employees397

CountryFR

SectorHealthcare

IndustryMedical Devices

ISINFR0011005933

Valuation

P/E (Trailing)—

P/E (Forward)1.95

PEG—

EV/EBITDA-5.11

EV/Revenue0.73

P/S0.17

P/B0.45

EPS (TTM)-4.03

EPS (Forward)0.46

52W Range

0.455038% of range1.570

52W High1.570 EUR

52W Low0.4550 EUR

Profitability

Gross Margin55.00%

Oper. Margin17.37%

EBITDA Margin-14.33%

Profit Margin-61.16%

ROE-166.59%

ROA-42.74%

Growth

Revenue Growth-5.80%

Earnings Growth—

Cash Flow & Leverage

Operating CF-6.40M USD

CapEx (TTM)2.92M USD

FCF Margin14.89%

FCF Yield87.57%

Net Debt57.82M USD

Net Debt/EBITDA-3.90

Balance Sheet

Debt/Equity1.76

Current Ratio0.64

Quick Ratio0.33

Book Value/Sh2.00 EUR

Cash/Share0.46 EUR

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 EUR

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio131.58%

Ex-Div DateMay 16, 2022

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.18.43M

Float7.63M

Insiders57.60%

Institutions0.00%

Technical

SMA 500.9136 (-3.9%)

SMA 2000.8931 (-1.7%)

Beta0.83

S&P 52W Chg14.58%

Avg Vol (30d)26.07K

Avg Vol (10d)31.49K

Technical Indicators

RSI (14)49.2

MACD-0.0094

MACD Signal-0.0056

MACD Hist.-0.0038

BB Upper0.9619 EUR

BB Middle0.9083 EUR

BB Lower0.8547 EUR

BB Width11.80%

ATR (14)0.0562 EUR

Vol Ratio (20d)0.69x